TARGETED-RELEASE BUDESONIDE
Clinical Indication
for treating primary IgA nephropathy
Comments
In line with NICE TA937
Date of classification
March 2024
Red
Medicines which should be prescribed only in a specialist setting usually within a secondary or tertiary care service. NB: Some highly specialised RED medicines e.g. injectable treatments for cancer are not included on the LLR APC website list.